# Old Republic International Corp: financial statements, quarterly

ORI · NYSE · CIK 74260 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ori.md) · [Financials](/companies/ori/financials.md) · [Filings](/companies/ori/filings.md) · [Insiders](/companies/ori/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ori/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,760](/filings/0000074260-25-000042.md) | [1,941](/filings/0000074260-25-000042.md) | [2,016](/filings/0000074260-26-000008.md) | [1,872](/filings/0000074260-26-000008.md) | [2,342](/filings/0000074260-26-000008.md) | [2,002](/filings/0000074260-26-000008.md) | [2,114](/filings/0000074260-26-000072.md) | [2,209](/filings/0000074260-26-000092.md) | [2,424](/filings/0000074260-26-000008.md) | [2,389](/filings/0000074260-26-000008.md) | [2,399](/filings/0000074260-26-000072.md) | [2,504](/filings/0000074260-26-000092.md) |
| Income tax | $m | [11.3](/filings/0000074260-24-000140.md) | [46.7 d](/filings/0000074260-26-000008.md) | [81.9](/filings/0000074260-25-000096.md) | [21.4](/filings/0000074260-25-000133.md) | [88.0](/filings/0000074260-25-000153.md) | [25.5 d](/filings/0000074260-26-000008.md) | [61.6](/filings/0000074260-26-000072.md) | [51.7](/filings/0000074260-26-000092.md) | [72.8](/filings/0000074260-25-000153.md) | [56.0 d](/filings/0000074260-26-000008.md) | [83.8](/filings/0000074260-26-000072.md) | [85.7](/filings/0000074260-26-000092.md) |
| Net income | $m | [52.6](/filings/0000074260-25-000042.md) | [191](/filings/0000074260-25-000042.md) | [317](/filings/0000074260-26-000008.md) | [91.8](/filings/0000074260-26-000008.md) | [339](/filings/0000074260-26-000008.md) | [105](/filings/0000074260-26-000008.md) | [245](/filings/0000074260-26-000072.md) | [204](/filings/0000074260-26-000092.md) | [280](/filings/0000074260-26-000008.md) | [206](/filings/0000074260-26-000008.md) | [330](/filings/0000074260-26-000072.md) | [322](/filings/0000074260-26-000092.md) |
| Diluted EPS | $ per share | [0.19](/filings/0000074260-25-000042.md) | [0.69](/filings/0000074260-25-000042.md) | [1.15](/filings/0000074260-26-000008.md) | [0.35](/filings/0000074260-26-000008.md) | [1.32](/filings/0000074260-26-000008.md) | [0.42](/filings/0000074260-26-000008.md) | [0.98](/filings/0000074260-26-000072.md) | [0.81](/filings/0000074260-26-000092.md) | [1.11](/filings/0000074260-26-000008.md) | [0.82](/filings/0000074260-26-000008.md) | [1.32](/filings/0000074260-26-000072.md) | [1.31](/filings/0000074260-26-000092.md) |
| Basic EPS | $ per share | [0.19](/filings/0000074260-25-000042.md) | [0.70](/filings/0000074260-25-000042.md) | [1.17](/filings/0000074260-26-000008.md) | [0.35](/filings/0000074260-26-000008.md) | [1.35](/filings/0000074260-26-000008.md) | [0.43](/filings/0000074260-26-000008.md) | [1.01](/filings/0000074260-26-000072.md) | [0.83](/filings/0000074260-26-000092.md) | [1.14](/filings/0000074260-26-000008.md) | [0.84](/filings/0000074260-26-000008.md) | [1.36](/filings/0000074260-26-000072.md) | [1.34](/filings/0000074260-26-000092.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000074260-23-000093.md) | [0.2](/filings/0000074260-25-000042.md) | [0.1](/filings/0000074260-24-000084.md) | [0.2](/filings/0000074260-24-000122.md) | [0.5](/filings/0000074260-24-000140.md) | [0.2](/filings/0000074260-26-000008.md) | [0.3](/filings/0000074260-25-000096.md) | [0.2](/filings/0000074260-25-000133.md) | [0.2](/filings/0000074260-25-000153.md) | [0.3](/filings/0000074260-26-000092.md) | [0.2](/filings/0000074260-26-000072.md) | [0.4](/filings/0000074260-26-000092.md) |
| Total assets | $bn | [26.4](/filings/0000074260-23-000093.md) | [26.5](/filings/0000074260-25-000042.md) | [27.1](/filings/0000074260-24-000084.md) | [27.5](/filings/0000074260-24-000122.md) | [28.8](/filings/0000074260-24-000140.md) | [27.8](/filings/0000074260-26-000008.md) | [28.0](/filings/0000074260-25-000096.md) | [29.3](/filings/0000074260-25-000133.md) | [30.3](/filings/0000074260-25-000153.md) | [29.9](/filings/0000074260-26-000092.md) | [29.6](/filings/0000074260-26-000072.md) | [31.6](/filings/0000074260-26-000092.md) |
| Total liabilities | $bn | [20.5](/filings/0000074260-23-000093.md) | [20.1](/filings/0000074260-25-000042.md) | [20.7](/filings/0000074260-24-000084.md) | [21.5](/filings/0000074260-24-000122.md) | [22.4](/filings/0000074260-24-000140.md) | [22.2](/filings/0000074260-26-000008.md) | [22.1](/filings/0000074260-25-000096.md) | [23.1](/filings/0000074260-25-000133.md) | [23.8](/filings/0000074260-25-000153.md) | [23.9](/filings/0000074260-26-000092.md) | [23.7](/filings/0000074260-26-000072.md) | [25.5](/filings/0000074260-26-000092.md) |
| Shareholders' equity | $bn | [5.9](/filings/0000074260-23-000093.md) | [6.4](/filings/0000074260-25-000042.md) | [6.4](/filings/0000074260-24-000084.md) | [6.0](/filings/0000074260-24-000122.md) | [6.4](/filings/0000074260-24-000140.md) | [5.6](/filings/0000074260-26-000008.md) | [5.9](/filings/0000074260-25-000096.md) | [6.2](/filings/0000074260-25-000133.md) | [6.4](/filings/0000074260-25-000153.md) | [5.9](/filings/0000074260-26-000092.md) | [5.9](/filings/0000074260-26-000072.md) | [6.1](/filings/0000074260-26-000092.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [350 d](/filings/0000074260-24-000140.md) | [283 d](/filings/0000074260-26-000008.md) | [160](/filings/0000074260-25-000096.md) | [237 d](/filings/0000074260-25-000133.md) | [475 d](/filings/0000074260-25-000153.md) | [362 d](/filings/0000074260-26-000008.md) | [232](/filings/0000074260-26-000072.md) | [134 d](/filings/0000074260-26-000092.md) | [564 d](/filings/0000074260-25-000153.md) | [235 d](/filings/0000074260-26-000008.md) | [281](/filings/0000074260-26-000072.md) | [200 d](/filings/0000074260-26-000092.md) |
| Dividends paid | $m | [67.6 d](/filings/0000074260-24-000140.md) | [66.9 d](/filings/0000074260-26-000008.md) | [71.5](/filings/0000074260-25-000096.md) | [69.1 d](/filings/0000074260-25-000133.md) | [66.4 d](/filings/0000074260-25-000153.md) | [64.9 d](/filings/0000074260-26-000008.md) | [568](/filings/0000074260-26-000072.md) | [73.0 d](/filings/0000074260-26-000092.md) | [70.9 d](/filings/0000074260-25-000153.md) | [70.8 d](/filings/0000074260-26-000008.md) | [694](/filings/0000074260-26-000072.md) | [76.6 d](/filings/0000074260-26-000092.md) |
| Share repurchases | $m | [126 d](/filings/0000074260-24-000140.md) | [55.8 d](/filings/0000074260-26-000008.md) | [194](/filings/0000074260-25-000096.md) | [409 d](/filings/0000074260-25-000133.md) | [165 d](/filings/0000074260-25-000153.md) | [174 d](/filings/0000074260-26-000008.md) | [25.3](/filings/0000074260-26-000072.md) | [0.0 d](/filings/0000074260-26-000092.md) | [43.3 d](/filings/0000074260-25-000153.md) | [55.2 d](/filings/0000074260-26-000008.md) | [160](/filings/0000074260-26-000072.md) | [60.2 d](/filings/0000074260-26-000092.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [280](/filings/0000074260-25-000042.md) | [277](/filings/0000074260-25-000042.md) | [275](/filings/0000074260-26-000008.md) | [266](/filings/0000074260-26-000008.md) | [257](/filings/0000074260-26-000008.md) | [253](/filings/0000074260-26-000008.md) | [250](/filings/0000074260-26-000072.md) | [251](/filings/0000074260-26-000092.md) | [251](/filings/0000074260-26-000008.md) | [251](/filings/0000074260-26-000008.md) | [249](/filings/0000074260-26-000072.md) | [246](/filings/0000074260-26-000092.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 241,432,922 at 2026-06-30, from the cover of the [10-Q filed 2026-07-31](/filings/0000074260-26-000092.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.